Document is current
Any future updates will be listed below
-
Authors
Gale, Robert Peter https://orcid.org/0000-0002-9156-1676
Hochhaus, Andreas https://orcid.org/0000-0003-0626-0834
- License Information
-
More Information
Article History
Received: 6 August 2025
Revised: 10 August 2025
Accepted: 26 August 2025
First Online: 11 September 2025
Competing interests
: RPG is a consultant to Antengene Biotech LLC; Consultant Shenzen TargetRx; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma, BeiGene and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support and Scientific Advisory Board, StemRad Ltd. AH Research support from Novartis, BMS, Pfizer, Incyte, Terns, Enliven; Honoraria: Novartis, Incyte.
Free to read: This content has been made available to all.
